PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsEsophagitis
MeSH D004941 - esophagitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D004935:Esophageal diseases
$
Success rate
D005759:Gastroenteritis
$
Success rate
D004941: 
Esophagitis
D004942:Peptic esophagitis
$
Success rate
D057765:Eosinophilic esophagitis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Salix PharmaceuticalsOmeprazole Zegerid  2004-06-15   
TevaEsomeprazole Esomeprazole Magnesium  2015-01-26   
Lansoprazole Lansoprazole  2009-11-10   
Omeprazole Omeprazole  2017-06-13   
Pantoprazole Pantoprazole  2007-08-02   
Sucralfate Sucralfate  1996-03-29   
Glenmark PharmaceuticalsEsomeprazole Esomeprazole Magnesium  2019-05-10   
Lansoprazole Lansoprazole  2012-05-18   
Omeprazole Omeprazole  2014-10-31   
IngenusPantoprazole Pantoprazole  2019-03-01   
MylanEsomeprazole Esomeprazole  2017-05-17   
Esomeprazole, Esomeprazole strontium Esomeprazole Magnesium  2015-08-02   
Lansoprazole Lansoprazole  2009-11-10   
Esomeprazole, Naproxen Naproxen Esomeprazole Magnesium  2021-07-20   
Omeprazole Omeprazole  2018-06-29   
Pantoprazole Pantoprazole  2011-01-19   
Sucralfate Sucralfate  2022-09-12   
XiromedLansoprazole Lansoprazole  2016-07-25   
Omeprazole Omeprazole  2020-12-10   
PerrigoEsomeprazole Esomeprazole Magnesium  2017-08-18   
Lansoprazole Lansoprazole  2012-05-18   
Omeprazole Omeprazole Bicarbonate  2016-07-15   
Omeprazole Omeprazole Magnesium  2015-07-30   
Pantoprazole Pantoprazole  2014-05-07   
Lansoprazole Prevacid  2009-05-18   
P&L Developments (PLD)Esomeprazole Esomeprazole Magnesium  2019-03-05   
Omeprazole Omeprazole Magnesium  2020-06-01   
GSKEsomeprazole Nexium Control  2013-08-26   
CiplaEsomeprazole Esomeprazole Magnesium  2020-03-23   
Pantoprazole Pantoprazole  2025-03-31   
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
100%
6/6
Phase 2
46%
6/13
Phase 3
63%
12/19
Approved: 5Overall Success rate: 29%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use